Sniffing for a solution: nasal spray tested for lingering COVID smell loss
NCT ID NCT05970731
Summary
This study tested whether a steroid nasal spray (beclomethasone) could improve smell function in people who lost their sense of smell for over 3 months after having COVID-19. Sixteen participants were randomly assigned to receive either the active spray or a placebo spray at two clinic visits. Researchers measured changes in smell ability and quality of life over three months to see if the treatment helped.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST ACUTE SEQUELAE COVID-19 HYPOSMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.